New data on Mpox vaccine effectiveness
A study at Charité — Universitätsmedizin Berlin has found that a single dose of the Imvanex vaccine provides protection against Mpox with 84% effectiveness. For people with HIV, however, a single dose of the vaccine fails to offer sufficient protection. All at-risk groups, and people with HIV in particular, should therefore receive the second dose […]
Public shows greater acceptance of RSV vaccine as vaccine hesitancy appears to have plateaued
A year after becoming available, vaccines to protect against RSV in newborns and older adults are being more widely accepted by the American public, according to a new Annenberg Public Policy Center (APPC) health survey conducted in November 2024. Over half of U.S. adults (52%) think the vaccine given to pregnant individuals to protect their […]
